Weighing Risks and Benefits of HIV Cure Research: Perspectives of People Living with HIV (PLWHIV)
by Drs. Karine Dube and Joseph D. Tucker How do key stakeholders understand the risks and benefits associated with participating in an HIV remission research study? This was the core question asked in our team’s research study published in PLoS ONE. … Read more
Employing Human Rights Frameworks to Define Government Obligations, Allocate Scarce Resources, and Engage Civil Society in Realizing Access to an HIV Cure
Benjamin Mason Meier, Adriane Gelpi, Matthew Kavanagh, Lisa Forman & Joseph Amon The HIV/AIDS pandemic has operationalized human rights for public health. Through the progression of HIV/AIDS policy, institutions of global health governance have looked to human rights in framing … Read more
“Exceptionally Desirable Material”: Leprosy Patients and Researchers at the Dawn of the Sulfone Age
by Raul Necochea When sulfone drugs proved effective at arresting leprosy infection and even reversing some of the disease’s effects in the early 1940s, a new stream of research began to flow, enabled by patients’ cooperation with researchers. While acknowledging … Read more
Delta Sigma Theta Sorority, Inc. Co-Hosts a Successful Red for Cure HIV Forum
By: Jennifer Hendrix, 2BeatHIV/searcHIV intern, NCCU student The Chapel Hill-Carrboro Area Alumnae Chapter of Delta Sigma Theta Sorority, Inc. and the 2BeatHIV Project co-hosted “Red for Cure”: A Forum on Black Women and HIV Cure on Saturday, February 27, 2016 … Read more
4 Facts to Know as you hear more about #charliesheen #mattlauer #HIV #HIVcure #2BeatHIV
by Allison Mathews, PhD, post-doc for searcHIV and 2BeatHIV News broke this morning announcing that Charlie Sheen has disclosed his status as HIV positive. We at the 2BeatHIV Project want you to know that we are proud of Charlie Sheen … Read more
HIV Remission: One Drug or Two?
by Dr. Joseph Tucker, searcHIV Principal Investigator The quest to achieve HIV remission has identified a wide range of potential candidates to decrease the size of the HIV reservoir, including broadly neutralizing antibodies, vaccines, traditional Chinese herbs, and gene editing … Read more
“Mississippi baby” – exploring the ethical complexities of HIV remission research in children
By Theresa Rossouw, MD, PhD, Johanna Crane, PhD, and Lisa Frenkel, MD Finding a cure for HIV has become the holy grail of HIV research. Fueled by the success of the “Berlin patient”, clinicians and researchers rushed to declare an … Read more
UNC – GSK Partnership Creates HIV Cure Research Center and QURA Therapeutics
On Monday May 11, 2015, UNC-Chapel Hill announced a new partnership with GlaxoSmithKline to create a dedicated HIV cure research center on campus and a jointly owned company, QURA Therapeutics, whose mission is to create a cure for HIV/AIDS. The … Read more
Funding HIV Cure, Funding Collaboration: amfAR Announces $100,000,000 Investment
By Adam Gilbertson The American Foundation for AIDS Research (amfAR) recently announced plans to implement a five-year research support strategy which will provide 100 million dollars for HIV cure-related research. Twenty million dollars is earmarked to establish the amfAR Institute … Read more
No Longer Anonymous: A Discussion of Timothy Ray Brown’s Personal Reflections
By MaryBeth Grewe Timothy Ray Brown, the first and only person to be considered cured of HIV, has been the topic of a great deal of discussion and commentary. From case reports to news articles and blog posts, many researchers, … Read more